ITPP + SR-9009 (Stenabolic) Tablets

ITPP SR-9009 (Stenabolic) Tablets

In different research models, ITPP SR-9009 (Stenabolic) tablets are being researched for their potential role in energy utilization and stamina.

Formulation Details:

Each tablet contains 50 mg ITPP 20 mg SR-9009 (Total: 70 mg per tablet)

Available Counts:

• 27 tablets (1890 mg total)
• 54 tablets (3780 mg total)

Overview of ITPP Tablets

ITPP, also known as Myo-Inositol Trispyrophosphate, is a lab-made modifier of hemoglobin. Researchers are investigating this compound for its potential to reduce hemoglobin affinity for oxygen and enhance oxygen release to tissues.

In different lab settings, researchers have noticed that ITPP may increase tissue oxygenation. Preliminary studies have shown that by doing this, the compound may improve endurance, delay fatigue, and support cardiovascular function.

Researchers have also explored its possible role in ischemia or tumor hypoxia, though findings remain limited. So more research is required!

Overview of SR-9009 (Stenabolic) Tablets

SR-9009, commonly known as Stenabolic, is a synthetic Rev-ErbA agonist. The compound is under research for its potential to boost metabolism and enhance endurance in laboratory models.

Researchers have found that SR-9009 may interact with a protein linked to circadian rhythm, energy production, and fat metabolism in experimental models. Though findings remain preliminary and limited to lab-based studies.

Working Mechanism of ITPP SR-9009 Tablets

Both ITPP and SR-9009 work differently under various research environments. Here is the breakdown of their working mechanism:

ITPP

Researchers have observed that ITPP may work by modulating hemoglobin, which increases oxygen release from red blood cells. In different research settings, it may alter the structure of hemoglobin to ease the release of oxygen to the areas where it is needed.

This helps deliver oxygen to the muscles and tissues where there are low-oxygen conditions, as observed in research settings. By doing so, ITPP may enhance endurance and cellular energy efficiency in research models.

Studies suggest ITPP may also support cellular metabolism. It does so by optimizing oxygen-dependent energy pathways in experimental models.

SR-9009 (Stenabolic)

SR-9009, a REV-ERB agonist, may work by activating the REV-ERB protein in different research models. REV-ERB are the nuclear receptors that may regulate the expression of various other genes. These genes control primary processes like circadian rhythm, metabolism, and mitochondrial function in research subjects.

By influencing the circadian rhythm, SR-9009 helps synchronize the sleep-wake cycles and daily energy patterns in research subjects. Though more research is needed!

In terms of metabolism, SR-9009 may regulate genes involved in glucose and fat metabolism. Preliminary studies have shown that regulating the genes may break down nutrients into energy.

Research has observed that SR-9009 may also enhance mitochondrial function. It may allow cells to produce more ATP, the energy currency from the available nutrients.

Combined Effect of ITPP SR-9009

The combination of ITPP SR-9009 may trigger synergistic effects in research models. Researchers have explored that ITPP may improve oxygen availability, while SR-9009 enhances cellular energy metabolism.

More research is needed to understand the full working mechanism of ITPP SR-9009 tablets.

Potential Benefits | ITPP

The following are the potential benefits of ITPP as observed in research models.

• Improves oxygen delivery to tissues in research subjects.
• Enhances endurance and exercise performance in research models.
• Increases oxygen utilization efficiency in research subjects.
• Supports muscle energy metabolism in research models.
• May reduce fatigue in research subjects.
• Improves hypoxia tolerance in research models.

Potential Side Effects | ITPP

The following are a few of the side effects observed in research subjects. However, long-term research is required to understand the full safety profile of this compound.

• Possible blood pressure changes in research subjects.
• Risk of altered oxygen saturation in research models.
• May cause mild cardiovascular strain in research subjects.
• Potential electrolyte imbalance in research models.
• Risk of increased oxidative stress in research subjects.
• Possible mild gastrointestinal discomfort in research models.

Potential Benefits | SR-9009

The following are the potential benefits of SR-9009. These are observed in limited preclinical studies.

• Increases energy expenditure in research subjects.
• Promotes fat metabolism in research models.
• Enhances mitochondrial function in research subjects.
• Improves endurance and exercise capacity in research models.
• Supports recovery and reduces fatigue in research subjects.
• May regulate circadian rhythm in research models.

Potential Side Effects | SR-9009

The following are a few of the side effects observed in research subjects. However, long-term research is required to understand the full safety profile of this compound.

• Possible disruption of circadian rhythm in research subjects.
• May alter heart rate or blood pressure in research models.
• Potential liver enzyme changes in research subjects.
• Risk of overactivation of metabolism in research models.
• Possible mild gastrointestinal discomfort in research subjects.
• Potential for excessive energy expenditure in research models.

Where to Buy ITPP SR-9009 Tablets

The best place to buy the ITPP SR-9009 tablets is undoubtedly Purerawz. The reason why we are so sure about our online shop is that we offer premium quality research chemicals at unbeatable prices. Additionally, we provide you with a proper certificate of analysis (COA) to ensure transparency. With secure transaction options, your data is saved with us.

FAQs

What is the half-life of ITPP and SR-9009 in experimental models?

In research models, ITPP has a short half-life of approximately 2/3 hours. SR-9009’s half-life ranges from 4-6 hours, depending on experimental conditions. Since there is limited data regarding the half-life of these compounds, more research is needed to understand their exact half-life.

How stable are ITPP and SR-9009 under lab conditions?

Both compounds are stable at room temperature when kept dry and protected from light. However, they are susceptible to hydrolysis or oxidation in aqueous solutions in research settings.

What is the shelf life of ITPP and SR-9009 for research purposes?

In properly stored lab settings, both ITPP and SR-9009 have a shelf life of 12-24 months, depending on storage conditions and formulation. However, more research is required due to a lack of data!

How do ITPP and SR-9009 degrade over time?

ITPP may hydrolyze into lower inositol phosphates, and SR-9009 may oxidize or lose potency when exposed to moisture or heat in experimental models.

What storage conditions are recommended for these compounds in research?

Both should be stored in airtight containers, away from light. It should be preferably stored at -20 degrees Celsius to minimize degradation in research subjects or models.

Disclaimer:

This information is for educational purposes only and not medical advice. Products are for research use only. Research must follow IRB or IACUC guidelines. Verify information independently before purchasing. By ordering, you agree to our Terms and Conditions. If you are not 100% satisfied with the product you received, please contact us at support@purerawz.co

ATTENTION: All our products are for LABORATORY AND RESEARCH PURPOSES ONLY, not for veterinary or human use.